Reported PBT up 76% but underlying profit up just 13.6% as debtors swell NZ$156m

What changed

Revenue rose 11.6% to NZ$508.8m and reported profit before tax jumped 75.9% to NZ$722.1m, with NPAT up 63.8% to NZ$692.9m. Operating cash flow improved 41.8% to NZ$586.0m. However, the release explicitly cites underlying profit growth of just 13.6%, indicating most of the IFRS profit step-up came from unrealised valuation gains on the village portfolio rather than trading performance. On the balance sheet, total assets expanded 19.6% to NZ$11.0b, gross borrowings rose 13.3% to NZ$2.58b, and net debt increased to roughly NZ$2.55b from NZ$2.25b. Trade debtors grew NZ$156.1m (+31.3%) to NZ$654.8m, well ahead of revenue growth.

What matters

• Underlying vs reported divergence. The 75.9% PBT print and the disclosed 13.6% underlying profit growth point in very different directions. Reported earnings include fair-value gains on the investment property portfolio, which are non-cash and procyclical to NZ retirement village pricing.
• Receivables build. Operating working capital rose NZ$155.6m, almost entirely in trade debtors, with implied debtor days lengthening from 399 to 470. For a retirement village model this partly reflects deferred resident receivables, but the magnitude of the step-up materially absorbs the operating cash improvement.
• Leverage direction. Net debt rose ~NZ$295m to NZ$2.55b despite the strong cash flow line, because capex stepped up to NZ$284.3m (55.9% of revenue versus 48.1% prior). The build-out is being part-funded by debt, and gearing is moving the wrong way even as equity grows on revaluation gains.

Expectations

No forward financial target or medium-term quantified guidance was extracted. The HY22 split shows 48.7% of FY22 revenue but only 40.6% of NPAT fell in the first half, confirming a second-half-weighted shape — which is consistent with valuation gains crystallising more heavily into the year-end IFRS result. The interim release also reset the dividend payout range to 30%–50% of underlying profit, but the FY22 declared dividend was not extracted, so payout cannot be assessed against the new band. Against the prior FY21 full-year dividend of 22.4 cps, that earlier base implied a 26.5% NPAT payout and 57.8% pre-lease FCF payout.

Quality of result

The PBT/NPAT growth gap (76% vs 64%) is genuinely tax-distorted: FY22 carried a NZ$29.2m tax expense (4.0% effective rate) versus a NZ$12.6m tax credit in FY21, so PBT is the cleaner growth read on this filing. But the more important quality flag is the gap between reported PBT growth (~76%) and management's stated underlying profit growth (~13.6%) — the IFRS uplift is dominated by property revaluations rather than trading. Cash quality is mixed: operating cash flow was strong in absolute terms, but pre-lease FCF/NPAT slipped from 45.8% to 43.5%, and the NZ$156m receivables build means a meaningful slice of reported earnings has not yet converted to cash. With capex now exceeding operating cash by capex stepping to NZ$284.3m, the business is in a clear investment phase rather than harvesting mode.

Unresolved

• The IFRS-to-underlying profit reconciliation, including the size of fair-value movements on investment properties, was not captured in the extraction.
• The composition of the NZ$654.8m trade debtors balance — particularly the split between current operating receivables and deferred resident-contract receivables — is not in the extracted fields, so the receivable-days deterioration cannot be cleanly attributed.
• No FY22 segment split for New Zealand vs Australia was extracted, leaving the Australia growth and margin trajectory opaque.
• The full-year FY22 dividend, payout ratio under the reset 30%–50% band, and any current-year debt/EBITDA covenant headroom are not visible.

This briefing cannot assess management's underlying profit bridge, the durability of investment-property valuation gains, or the embedded value of the resale bank and forward village pipeline.

Key metrics

Segment breakdown

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.